Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - vincristine sulfate 2mg;  ;  ;   - injection with diluent - 2 mg - active: vincristine sulfate 2mg       excipient: lactose monohydrate benzyl alcohol sodium chloride water for injection

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - vincristine sulfate 5mg;  ;  ;   - injection with diluent - 5 mg - active: vincristine sulfate 5mg       excipient: lactose monohydrate benzyl alcohol sodium chloride water for injection

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - vincristine sulfate - solution for injection - 1mg, 5mg (douglas) - active: vincristine sulfate

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - vincristine sulfate 1mg - solution for injection - 1 mg - active: vincristine sulfate 1mg excipient: lactose monohydrate water for injection sodium chloride water for injection

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - vincristine sulfate 1 mg/ml - solution for injection - 1 mg/ml - active: vincristine sulfate 1 mg/ml excipient: acetic acid methyl hydroxybenzoate propyl hydroxybenzoate sodium acetate trihydrate water for injection

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - vincristine sulfate 1 mg/ml - solution for injection - 1 mg/ml - active: vincristine sulfate 1 mg/ml excipient: mannitol water for injection

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - vincristine sulfate 2mg - solution for injection - 2 mg - active: vincristine sulfate 2mg excipient: lactose monohydrate water for injection sodium chloride water for injection

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - vincristine sulfate 5mg - solution for injection - 5 mg - active: vincristine sulfate 5mg excipient: lactose monohydrate water for injection sodium chloride water for injection

Australie - anglais - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sodium hydroxide; sulfuric acid - vincristine is used primarily in the treatment of acute leukaemia, usually as a component of various chemotherapeutic regimens. it has also been used as part of combination therapy in the treatment of hodgkin's disease, non-hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, wilm's tumour, osteogenic sarcoma, mycosis fungoides, ewing's sarcoma, carcinoma of the uterine cervix, breast cancer, malignant melanoma, oat-cell carcinoma of the lung and gynaecological tumours of childhood. vincristine may be useful in patients with true idiopathic thrombocytopenic purpura resistant to the usual treatment, but not recommended as primary treatment for this disorder.

Malaisie - anglais - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hospira malaysia sdn bhd - vincristine sulphate -